Evidence map›Paper›PMID 33526872›Full record

ArticleCommunications biology2021

Kaiso (ZBTB33) subcellular partitioning functionally links LC3A/B, the tumor microenvironment, and breast cancer survival.

Sandeep K Singhal, Jung S Byun, Samson Park, Tingfen Yan, Ryan Yancey, Ambar Caban, Sara Gil Hernandez, Stephen M Hewitt, Heike Boisvert, Stephanie Hennek and 13 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. New Spatial Phenotypes from Imaging Uncover Survival Differences for Breast Cancer Patients.ACM-BCB ... ... : the ... ACM Conference on Bioinformatics, Computational Biology and Biomedicine. ACM Conference on Bioinformatics, Computational Biology and Biomedicine · 2024
    Article
  5. Article
  6. Multiplex Immunofluorescence: A Powerful Tool in Cancer Immunotherapy.International journal of molecular sciences · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 7 institutions in 2 countries.

Sandeep K Singhal *Department of Pathology, School of Medicine and Health Sciences, Department of Computer Science, School of Electrical Engineering and Computer Science, University of North Dakota, Grand Forks, ND, USA.ORCID 0000-0002-3486-067X
Jung S Byun *Division of Intramural Research, National Institutes of Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD, USA.
Samson ParkDivision of Intramural Research, National Institutes of Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD, USA.
Tingfen YanDivision of Intramural Research, National Institutes of Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD, USA.
Ryan YanceyDepartment of Pathology and Cell Biology, Columbia University Irvine Medical Center, New York, NY, USA.ORCID 0000-0002-4207-0125
Ambar CabanDepartment of Pathology and Cell Biology, Columbia University Irvine Medical Center, New York, NY, USA.
Sara Gil HernandezDivision of Intramural Research, National Institutes of Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD, USA.
Stephen M HewittLaboratory of Pathology, Centers for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Heike BoisvertUltivue, Inc, Cambridge, MA, USA.
Stephanie HennekUltivue, Inc, Cambridge, MA, USA.
Mark BobrowUltivue, Inc, Cambridge, MA, USA.
Md Shakir Uddin AhmedDepartment of Biology and Center for Cancer Research, Tuskegee University, Tuskegee, Al, USA.
Jason WhiteDepartment of Biology and Center for Cancer Research, Tuskegee University, Tuskegee, Al, USA.
Clayton YatesDepartment of Biology and Center for Cancer Research, Tuskegee University, Tuskegee, Al, USA.ORCID 0000-0001-5420-9852
Andrew AukermanDepartment of Pathology and Cell Biology, Columbia University Irvine Medical Center, New York, NY, USA.
Rami VanguriDepartment of Pathology and Cell Biology, Columbia University Irvine Medical Center, New York, NY, USA.
Rohan BarejaDepartment Computer Science Department, Columbia University, New York, NY, USA.
Romina LenciDepartment of Pathology and Cell Biology, Columbia University Irvine Medical Center, New York, NY, USA.ORCID 0000-0002-0025-3134
Paula Lucia FarréLaboratorio de Oncologıa Molecular y Nuevos Blancos Terapeuticos, Instituto de Biologıa y Medicina Experimental (IBYME), CONICET, Buenos Aires, Argentina.
Adriana De SierviLaboratorio de Oncologıa Molecular y Nuevos Blancos Terapeuticos, Instituto de Biologıa y Medicina Experimental (IBYME), CONICET, Buenos Aires, Argentina.
Anna María NápolesDivision of Intramural Research, National Institutes of Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD, USA.
Nasreen VohraBrody School of Medicine, East Carolina University, Greenville, NC, USA.ORCID 0000-0002-6411-3042
Kevin GardnerDepartment of Pathology and Cell Biology, Columbia University Irvine Medical Center, New York, NY, USA. klg2160@cumc.columbia.edu.ORCID 0000-0001-8018-4353
Columbia University · USNational Institutes of Health · USCenter for Cancer Research · USConsejo Nacional de Investigaciones Científicas y Técnicas · ARColumbia University Irving Medical Center · USEast Carolina University · USUniversity of North Dakota · US

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
Tuskegee University Center for Biomedical Research/ Research Centers at Minority InstitutionsU54MD007585 · NIMHD · TUSKEGEE UNIVERSITY · PI Jason Anthony White · 2017 to 2026
$29.4M
Tracking and Evaluation CoreU54GM128729 · NIGMS · UNIVERSITY OF NORTH DAKOTA · PI BASSON, MARC D. · 2018 to 2022
$20.3M
Research Education CoreU54CA118623 · NCI · TUSKEGEE UNIVERSITY · PI Vivian L Carter, TIMOTHY TURNER · 2005 to 2026
$20.2M
Experimental Pathology Laboratory (EPL)ZICBC011638 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HEWITT, STEPHEN · 2015 to 2025
$16.6M
Translating Behavioral Interventions for Health Disparity PopulationsZIAMD000014 · NIMHD · NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES · PI CHOI, KELVIN · 2018 to 2023
$4.8M
The linkage between Race, Kaiso and the tumor microenvironment in breast cancer health disparitiesR01CA253368 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GARDNER, KEVIN L. · 2020 to 2024
$3.3M
NCI NIH HHS P30 CA013696NCI NIH HHS R01 CA253368NCI NIH HHS U54 CA118623NIGMS NIH HHS U54 GM128729NIMHD NIH HHS U54 MD007585
6 · The paper itself

Abstract

The use of digital pathology for the histomorphologic profiling of pathological specimens is expanding the precision and specificity of quantitative tissue analysis at an unprecedented scale; thus, enabling the discovery of new and functionally relevant histological features of both predictive and prognostic significance. In this study, we apply quantitative automated image processing and computational methods to profile the subcellular distribution of the multi-functional transcriptional regulator, Kaiso (ZBTB33), in the tumors of a large racially diverse breast cancer cohort from a designated health disparities region in the United States. Multiplex multivariate analysis of the association of Kaiso's subcellular distribution with other breast cancer biomarkers reveals novel functional and predictive linkages between Kaiso and the autophagy-related proteins, LC3A/B, that are associated with features of the tumor immune microenvironment, survival, and race. These findings identify effective modalities of Kaiso biomarker assessment and uncover unanticipated insights into Kaiso's role in breast cancer progression.

Indexed as

Tumor MicroenvironmentAutomation, LaboratoryBreast NeoplasmsCell Line, TumorFemaleFluorescent Antibody TechniqueGene Expression Regulation, NeoplasticHumansImage Interpretation, Computer-AssistedMicroscopy, FluorescenceMicrotubule-Associated ProteinsPrognosisRetrospective StudiesRisk AssessmentRisk FactorsSignal TransductionMAP1LC3A protein, humanMAP1LC3B protein, humanMicrotubule-Associated ProteinsTranscription FactorsZBTB33 protein, human

Identifiers

PMID33526872
PMCPMC7851134
OpenAlexW3128345652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.